Predictive Oncology (POAI) Competitors $0.69 -0.03 (-3.82%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends POAI vs. NRXS, MBOT, NEPH, LUCY, IINN, LFWD, MHUA, SSKN, LYRA, and PYPDShould you be buying Predictive Oncology stock or one of its competitors? The main competitors of Predictive Oncology include NeurAxis (NRXS), Microbot Medical (MBOT), Nephros (NEPH), Innovative Eyewear (LUCY), Inspira Technologies Oxy B.H.N. (IINN), ReWalk Robotics (LFWD), Meihua International Medical Technologies (MHUA), STRATA Skin Sciences (SSKN), Lyra Therapeutics (LYRA), and PolyPid (PYPD). These companies are all part of the "medical equipment" industry. Predictive Oncology vs. NeurAxis Microbot Medical Nephros Innovative Eyewear Inspira Technologies Oxy B.H.N. ReWalk Robotics Meihua International Medical Technologies STRATA Skin Sciences Lyra Therapeutics PolyPid NeurAxis (NASDAQ:NRXS) and Predictive Oncology (NASDAQ:POAI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation, earnings and community ranking. Which has more risk & volatility, NRXS or POAI? NeurAxis has a beta of 4.15, suggesting that its share price is 315% more volatile than the S&P 500. Comparatively, Predictive Oncology has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500. Which has better earnings & valuation, NRXS or POAI? Predictive Oncology has lower revenue, but higher earnings than NeurAxis. NeurAxis is trading at a lower price-to-earnings ratio than Predictive Oncology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeurAxis$2.46M6.82-$14.63M-$1.84-1.30Predictive Oncology$1.48M3.10-$13.98M-$3.05-0.23 Does the MarketBeat Community believe in NRXS or POAI? Predictive Oncology received 148 more outperform votes than NeurAxis when rated by MarketBeat users. However, 100.00% of users gave NeurAxis an outperform vote while only 64.22% of users gave Predictive Oncology an outperform vote. CompanyUnderperformOutperformNeurAxisOutperform Votes1100.00% Underperform VotesNo VotesPredictive OncologyOutperform Votes14964.22% Underperform Votes8335.78% Does the media prefer NRXS or POAI? In the previous week, NeurAxis' average media sentiment score of 0.00 equaled Predictive Oncology'saverage media sentiment score. Company Overall Sentiment NeurAxis Neutral Predictive Oncology Neutral Do analysts rate NRXS or POAI? Predictive Oncology has a consensus target price of $3.00, suggesting a potential upside of 335.03%. Given Predictive Oncology's stronger consensus rating and higher probable upside, analysts plainly believe Predictive Oncology is more favorable than NeurAxis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeurAxis 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Predictive Oncology 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is NRXS or POAI more profitable? NeurAxis has a net margin of -492.76% compared to Predictive Oncology's net margin of -1,012.32%. NeurAxis' return on equity of 0.00% beat Predictive Oncology's return on equity.Company Net Margins Return on Equity Return on Assets NeurAxis-492.76% N/A -641.25% Predictive Oncology -1,012.32%-286.30%-122.11% Do institutionals & insiders hold more shares of NRXS or POAI? 11.8% of NeurAxis shares are owned by institutional investors. Comparatively, 9.0% of Predictive Oncology shares are owned by institutional investors. 15.2% of NeurAxis shares are owned by company insiders. Comparatively, 3.4% of Predictive Oncology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryNeurAxis beats Predictive Oncology on 9 of the 15 factors compared between the two stocks. Ad ProsperityPubCrypto’s hidden gem + greatest crypto bull run in history = $$$?You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem Get Predictive Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for POAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart POAI vs. The Competition Export to ExcelMetricPredictive OncologySurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.60M$9.53B$5.13B$9.07BDividend YieldN/A1.38%5.08%4.23%P/E Ratio-0.2319.5689.5817.17Price / Sales3.1032.801,116.12116.95Price / CashN/A22.3742.8237.86Price / Book0.345.494.774.78Net Income-$13.98M$182.72M$120.15M$225.60M7 Day Performance-11.58%-4.48%-1.92%-1.23%1 Month Performance0.09%-4.23%11.47%3.36%1 Year Performance-76.70%-12.17%30.54%16.60% Predictive Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)POAIPredictive Oncology2.2483 of 5 stars$0.69-3.8%$3.00+335.0%-76.3%$4.60M$1.48M-0.2330News CoverageGap UpNRXSNeurAxisN/A$2.46-0.8%N/A+13.7%$17.17M$2.46M-1.3519Gap DownMBOTMicrobot Medical2.6578 of 5 stars$1.00flat$7.00+600.0%-28.7%$16.93MN/A-1.2520Positive NewsNEPHNephros1.6925 of 5 stars$1.54-0.6%$5.00+224.7%-50.0%$16.24M$13.55M-17.2230Gap UpLUCYInnovative Eyewear1.7088 of 5 stars$6.15+0.7%$20.00+225.2%-34.1%$15.02M$1.56M-0.639Positive NewsIINNInspira Technologies Oxy B.H.N.0.3085 of 5 stars$1.12-4.3%N/A-21.2%$14.14MN/A0.0020LFWDReWalk Robotics3.3589 of 5 stars$1.52-7.9%$13.00+755.3%N/A$13.39M$13.85M-0.6660Positive NewsGap UpMHUAMeihua International Medical Technologies0.6851 of 5 stars$0.51+1.3%N/A-87.5%$12.73M$94.25M0.00620Positive NewsSSKNSTRATA Skin Sciences1.0348 of 5 stars$2.99-0.3%N/A-54.7%$12.47M$32.68M-1.11120LYRALyra Therapeutics2.4114 of 5 stars$0.19+2.8%$4.50+2,297.4%-96.0%$12.29M$1.47M-0.1250Gap DownPYPDPolyPid2.3376 of 5 stars$2.37-9.2%$12.00+406.3%-15.5%$11.38MN/A-0.3080Analyst RevisionHigh Trading Volume Related Companies and Tools Related Companies NeurAxis Competitors Microbot Medical Competitors Nephros Competitors Innovative Eyewear Competitors Inspira Technologies Oxy B.H.N. Competitors ReWalk Robotics Competitors Meihua International Medical Technologies Competitors STRATA Skin Sciences Competitors Lyra Therapeutics Competitors PolyPid Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:POAI) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Predictive Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Predictive Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free POAI Stock Alerts